BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mathie A, Veale EL, Golluscio A, Holden RG, Walsh Y. Pharmacological Approaches to Studying Potassium Channels. Handb Exp Pharmacol 2021;267:83-111. [PMID: 34195873 DOI: 10.1007/164_2021_502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Vieira‐coelho MA, Martel F. Inhibition of kidney potassium channels by fluoxetine: In vivo and in vitro studies. Fundamemntal Clinical Pharma 2022. [DOI: 10.1111/fcp.12833] [Reference Citation Analysis]
2 Luis E, Anaya-hernández A, León-sánchez P, Durán-pastén ML. The Kv10.1 Channel: A Promising Target in Cancer. IJMS 2022;23:8458. [DOI: 10.3390/ijms23158458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rajabian A, Rajabian F, Babaei F, Mirzababaei M, Nassiri-Asl M, Hosseinzadeh H. Interaction of Medicinal Plants and Their Active Constituents With Potassium Ion Channels: A Systematic Review. Front Pharmacol 2022;13:831963. [PMID: 35273505 DOI: 10.3389/fphar.2022.831963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lind L, Araujo JA, Barchowsky A, Belcher S, Berridge BR, Chiamvimonvat N, Chiu WA, Cogliano VJ, Elmore S, Farraj AK, Gomes AV, McHale CM, Meyer-Tamaki KB, Posnack NG, Vargas HM, Yang X, Zeise L, Zhou C, Smith MT. Key Characteristics of Cardiovascular Toxicants. Environ Health Perspect 2021;129:95001. [PMID: 34558968 DOI: 10.1289/EHP9321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]